Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GNPS-fenziwangluo-hezao-20240606-pos

ABSTRACT: compound,Ecklonia cava,UHPLC-Q-Orbitrap HRMS,representation,Identification

INSTRUMENT(S): UHPLC-Q-Orbitrap HRMS

ORGANISM(S): Ecklonia Cava

SUBMITTER: Li Yu

PROVIDER: MSV000094955 | GNPS | Thu Jun 06 19:44:00 BST 2024

REPOSITORIES: GNPS

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

GNPS-fenziwangluo-hezao-20240606-neg

Project description:compound,Ecklonia cava,UHPLC-Q-Orbitrap HRMS,representation,Identification

2024-06-06 | MSV000094954 | GNPS

GNPS-fenziwangluo-hezao-20240610-neg

Project description:Ecklonia cava UHPLC-Q-Orbitrap HRMS Identification of compounds

2024-06-10 | MSV000094965 | GNPS

GNPS-fenziwangluo-hezao-20240614-neg

Project description:Ecklonia cava UHPLC-Q-Orbitrap HRMS Identification of compounds Component characterization

2024-06-13 | MSV000095031 | GNPS

GNPS-fenziwangluo-huzhang-20240610-pos

Project description:Ecklonia cava UHPLC-Q-Orbitrap HRMS Identification of compounds

2024-06-10 | MSV000094964 | GNPS

Homo sapiens

Project description:etabolomics and Lipidomics of Plasma Biomarkers for Tuberculosis Diagnostics using UHPLC-HRMS (PRJCA041719)

| PRJDB37149 | ENA

GNPS-fenziwangluo-hezao-20240601

Project description:Non-targeted metabolomics,natural product,Compound extraction, isolation, characterization

2024-05-31 | MSV000094916 | GNPS

Project description:Effects of Ecklonia cava susp. stolonifera and Eisenia bicyclis on human faecal culture

| PRJNA1241439 | ENA

Pharmacokinetics and tissue distribution of dual PPARα/γ agonist gigantol in mice

Project description:Gigantol is a bioactive compound in Dendrobium officinale with a wide range of pharmacological properties. This study developed an ultrahigh-performance liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry (UHPLC-Q-TOF/MS) method for quantifying gigantol, which was subsequently applied to assess its pharmacokinetics and tissue distribution in Kunming mice. Additionally, the effects of gigantol on peroxisome proliferator-activated receptors (PPARs) were investigated. The UHPLC-Q-TOF/MS method was validated following the guidelines provided by the FDA and EMA for bioanalytical methods. Pharmacokinetic analysis revealed that gigantol exhibits a non-linear kinetic profile. Tissue distribution studies demonstrated high concentrations of gigantol in the liver and lungs. RNA sequencing (RNA-seq) indicated significant enrichment of PPAR signaling pathways in the KEGG database during gigantol-induced gene expression changes in the liver of Kunming mice. Molecular fingerprinting, docking studies and dual luciferase reporter assays confirmed that gigantol is a dual PPARα/γ agonist. These findings provide valuable insights for preclinical research on gigantol.

2025-12-06 | GSE312718 | GEO

LC-HRMS Data of Murraya paniculata

Project description:This LC-HRMS Data of Murraya paniculata was obtained from Orbitrap Eclipse Tribrid Mass Spectrometer with Nano LC and UHPLC and contains complex profile of bioactive compounds, including alkaloids, flavonoids, and coumarins.

| MSV000095737 | MassIVE

Salinity changes and parasite infections induce metabolic shifts in cell metabolome of harmful algae

Project description:Metabolic profiling from microalgal methanolic extracts using UHPLC-HRMS (Orbitrap Q Exactive). Dinoflagellate Alexandrium minutum were either healthy or infected with alveolate parasite Parvilucifera infectans, and cultivated under 20 PSU or 32 PSU. Samples were unpaired and extracted on Day 7, 14 and 21. The samples were processed using ZIC-HILIC chromatography to identify polar metabolites, followed by ddMS aquisition in the positive polarity mode. The supplementary files include, the study and result files from Compound Discoverer, the metadata table with normalization factor, sample code and conditions. The raw files of standards used confirm retention time and MS2 fragments of samples are included as well.

| MSV000099020 | MassIVE

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data